Generics - Sun Pharmaceutical Industries, Patents

Filter

Popular Filters

Indian drugmakers set to capitalize on Cymbalta generics

10-02-2014

Approval for the generic version of Eli Lilly’s Cymbalta duloxetine by the US health regulator (The…

Asia-PacificAurobindo PharmaCymbaltaDr Reddy's LaboratoriesDuloxetine HclEli LillyGenericsHealthcareIndiaLupinMarkets & MarketingNeurologicalPatentsSun Pharmaceutical IndustriesTorrent Pharmaceuticals

Pfizer in $2.15 billion settlement from Teva and Sun for infringement of Protonix patent

12-06-2013

Global pharma behemoth Pfizer (NYSE: PFE) today (June 12) said it has reached a $2.15 billion settlement…

Gastro-intestinalsGenericsLegalNorth AmericaPatentsPfizerPharmaceuticalProtonixSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

US Supreme Court ruling in Novo Nordisk Prandin case favors generic drugmakers

18-04-2012

The US Supreme Court yesterday reversed the US Court of Appeals for the Federal Circuit's April 2010…

Caraco PharmaceuticalDiabetesGenericsLegalNorth AmericaNovo NordiskPatentsPharmaceuticalPrandiMetPrandinrepaglinideSun Pharmaceutical Industries

Sanofi prevails over Sun Pharma in Eloxatin patent suit; another generic Lovenox approved

20-09-2011

There was good and bad news for French drug major Sanofi (Euronext: SAN) yesterday, when the US District…

AmphastarCardio-vascularEloxatinGenericsLovenoxOncologyPatentsPharmaceuticalSanofiSun Pharmaceutical IndustriesWatson Pharmaceuticals

Company Spotlight

ImmunoGen

ImmunoGen

Back to top